Previous 10 | Next 10 |
VANCOUVER, BC / ACCESSWIRE / January 14, 2022 / The Power Play by The Market Herald has announced the release of new interviews with EarthRenew, Algernon Pharmaceuticals and Rockwell Medical discussing their latest press releases. The Power Play by The Market Herald provides investors with ...
3 Penny Stocks to Add to Your January 2022 Watchlist As January 13th has become a volatile trading day for penny stocks and blue chips, many investors are looking for the best small-caps to buy. Now, it can be challenging to find penny stocks that are worth buying with so much going...
-Commercial launch expected in June/July 2022- -Rockwell Medical has an exclusive license agreement with Jeil Pharmaceutical Co., Ltd., for the rights to Triferic ® and Triferic ® AVNU in South Korea- -More than 82,000 patients receiving hemodialysis an...
WIXOM, Mich., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for pa...
WIXOM, Mich., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that it received fee...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We’re halfway through the week and with that comes a look at the biggest pre-market stock movers for Wednesday! Source: f11photo/Shutterstock.com Earnings reports, study results, a rever...
WIXOM, Mich., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced the publication of r...
Rockwell Medical, Inc. (RMTI) Q3 2021 Earnings Conference Call November 15, 2021, 04:00 PM ET Company Participants Jason Finkelstein - SVP, Argot Partners, IR Russell Ellison - President & CEO Russell Skibsted - EVP, CFO & Chief Business Officer Marc Hoffman - Chief Medical Officer Co...
Rockwell Medical (NASDAQ:RMTI): Q3 GAAP EPS of -$0.08 misses by $0.01. Revenue of $16M (+4.7% Y/Y) misses by $2.18M. Press Release For further details see: Rockwell Medical EPS misses by $0.01, misses on revenue
News, Short Squeeze, Breakout and More Instantly...
Rockwell Medical Inc. Company Name:
RMTI Stock Symbol:
NASDAQ Market:
Rockwell Medical Inc. Website:
Reports record net sales of $22.7 million for the first quarter of 2024, an increase of 25% over net product sales and a 15% increase over net sales for the same period in 2023. Reports record gross profit of $3.1 million for the first quarter of 2024, an increase of 18% over the same per...
Enters into new direct supply agreement with one of the largest health systems in the Mountain West Region Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to d...